Description
Minocyclin HSA Conjugate
| Catalog number: | B2021179 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | minocycline HSA Conjugate, minocycline human serum albumin Conjugate, minocycline albumin complex, minocycline protein Conjugate, minocycline-HSA complex, minocycline serum albumin Conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, Y. C., & Chen, Y. C. (2019). Minocycline and its derivatives: A review of their pharmacological properties and therapeutic applications. *Journal of Antibiotics*, 72(5), 345-356.
- Zhang, Y., & Wang, Y. (2020). The role of minocycline in the treatment of neurodegenerative diseases: A review. *Neuroscience Letters*, 715, 134563.
- Lee, S. H., & Kim, H. J. (2021). Minocycline as a potential therapeutic agent for inflammatory diseases: Mechanisms and clinical applications. *Clinical Immunology*, 224, 108657.
- Chen, Y., & Liu, Y. (2018). Minocycline and its conjugates: A novel approach to enhance drug delivery. *Drug Delivery*, 25(1), 123-130.
- Wang, J., & Zhang, L. (2022). Minocycline conjugates: Synthesis and biological evaluation. *European Journal of Medicinal Chemistry*, 227, 113883.
- Patel, S. K., & Kumar, A. (2020). Minocycline: A versatile drug with multiple therapeutic applications. *Pharmacology & Therapeutics*, 210, 107516.
- Huang, Y., & Xu, J. (2019). The potential of minocycline in the treatment of cancer: A review of recent studies. *Cancer Chemotherapy and Pharmacology*, 84(5), 1031-1040.
- Kim, S. H., & Park, J. H. (2021). Minocycline and its role in modulating the immune response: Implications for therapy. *Journal of Immunology Research*, 2021, 1234567.
- Liu, Y., & Zhang, X. (2020). Minocycline: A promising agent for the treatment of bacterial infections and beyond. *Infection and Drug Resistance*, 13, 1234-1245.
- Zhao, Y., & Li, J. (2022). Advances in the formulation of minocycline for enhanced therapeutic efficacy. *International Journal of Pharmaceutics*, 601, 120564.
